Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat-Reference-Cited by-同舟云学术

Effect of chlorophenoxyisobutyric acid (CPIB) on fat-mobilizing lipolysis and cyclic AMP levels in rat epididymal fat

Published:1972-11 Issue:3 Volume:16 Page:349-357
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Carlson L.A.,Walldius G.,Butcher R.W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Modification and distribution of lipids by ethylchlorophenoxyisobutyrate;Thorp;Nature,1962

2. Drugs inhibiting cholesterol biosynthesis, with special reference to clofibrate;Steinberg,1970

3. The effect of chlorophenoxyisobutyric acid on the release of free fatty acids from isolated adipose tissue in vitro;Barrett;Brit. J. Pharmacol.,1966

4. Effect of CPIB ester on plasma free fatty acid levels in man;Rifkind;Metabolism,1966

5. Effect of ethylchlorophenoxyisobutyrate on weight, plasma volume, total body water and free fatty acids;Macmillan;Lancet,1965

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PHARMACOLOGICAL APPROACHES AND STRATEGIES FOR THERAPEUTIC MODULATION OF FIBRINOGEN;Thrombosis Research;1997-07

2. The effects of combined treatment with beta1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects;British Journal of Clinical Pharmacology;1997-05

3. A comparison of the effects of fluvastatin and bezafibrate on exercise metabolism: a placebo‐controlled study in healthy normolipidaemic subjects;British Journal of Clinical Pharmacology;1996-05

4. Drugs Affecting Triglycerides;Cardiology;1991

5. Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjects.;Journal of Lipid Research;1990-04